These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3991728)

  • 1. Comparison studies of oncogenes in retinoblastoma and neuroblastoma.
    Lee WH; Murphree AL; Benedict WF
    Prog Clin Biol Res; 1985; 175():131-9. PubMed ID: 3991728
    [No Abstract]   [Full Text] [Related]  

  • 2. [Absence of point mutation in the 12th codon of the c-Ha-rasl transforming genes of human breast and stomach cancer, melanoma and neuroblastoma].
    Kniazev PG; Schäfer R; Willecke K; Seĭts IF
    Dokl Akad Nauk SSSR; 1985; 282(6):1487-9. PubMed ID: 4028949
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular biology aspects of neuroblastoma].
    Schuster V; Kreth HW
    Monatsschr Kinderheilkd; 1987 Oct; 135(10):672-6. PubMed ID: 3317004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
    Amler LC; Schürmann J; Schwab M
    Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oncogenes and neuronal differentiation].
    Sugimoto Y; Noda M
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(4 Suppl):655-62. PubMed ID: 2185499
    [No Abstract]   [Full Text] [Related]  

  • 7. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
    Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R
    Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of oncogene expression in normal and tumorous human tissues].
    Nelkov AM
    Dokl Akad Nauk SSSR; 1984; 276(5):1257-9. PubMed ID: 6206991
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.
    Leone A; Seeger RC; Hong CM; Hu YY; Arboleda MJ; Brodeur GM; Stram D; Slamon DJ; Steeg PS
    Oncogene; 1993 Apr; 8(4):855-65. PubMed ID: 8384356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology.
    Weichselbaum RR; Beckett M; Diamond A
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2106-9. PubMed ID: 3162593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines.
    Ichimiya S; Nimura Y; Seki N; Ozaki T; Nagase T; Nakagawara A
    Med Pediatr Oncol; 2001 Jan; 36(1):132-4. PubMed ID: 11464865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P; Barbany G; Dominici C; Castello MA; Raschellá G; Persson H
    Cancer Res; 1993 May; 53(9):2044-50. PubMed ID: 8481906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the amplified domain in human neuroblastoma cells.
    Michitsch RW; Montgomery KT; Melera PW
    Mol Cell Biol; 1984 Nov; 4(11):2370-80. PubMed ID: 6549047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
    McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
    Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma.
    Molenaar JJ; van Sluis P; Boon K; Versteeg R; Caron HN
    Genes Chromosomes Cancer; 2003 Mar; 36(3):242-9. PubMed ID: 12557224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of embryonal tumours of childhood: retinoblastoma, Wilms' tumour and neuroblastoma.
    Brodeur GM
    Cancer Surv; 1995; 25():67-99. PubMed ID: 8718513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression.
    Zhang K; Nowak I; Rushlow D; Gallie BL; Lohmann DR
    Hum Mutat; 2008 Apr; 29(4):475-84. PubMed ID: 18181215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
    Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of DEAD box 1 in retinoblastoma and neuroblastoma.
    Godbout R; Li L; Liu RZ; Roy K
    Future Oncol; 2007 Oct; 3(5):575-87. PubMed ID: 17927523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenetics: progress in malignancy.
    Robertson M
    Nature; 1984 Jun 7-13; 309(5968):512-3. PubMed ID: 6728005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.